Ekachai Medical Care PCL (BKK:EKH)
Thailand
· Delayed Price · Currency is THB 6.20
+0.05 (0.81%)
Apr 18, 2025, 4:36 PM ICT
Ekachai Medical Care PCL Income Statement
Financials in millions THB. Fiscal year is January - December.
Millions THB. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Operating Revenue | 1,307 | 1,209 | 1,049 | 1,146 | 645.75 | Upgrade
|
| Revenue | 1,307 | 1,209 | 1,049 | 1,146 | 645.75 | Upgrade
|
| Revenue Growth (YoY) | 8.13% | 15.27% | -8.54% | 77.52% | -28.68% | Upgrade
|
| Cost of Revenue | 718.76 | 669.22 | 609 | 602.79 | 449.81 | Upgrade
|
| Gross Profit | 588.13 | 539.39 | 439.51 | 543.57 | 195.94 | Upgrade
|
| Selling, General & Admin | 281.17 | 223.9 | 197.33 | 173.05 | 130.58 | Upgrade
|
| Operating Expenses | 281.17 | 223.9 | 197.33 | 173.05 | 130.58 | Upgrade
|
| Operating Income | 306.95 | 315.49 | 242.18 | 370.52 | 65.36 | Upgrade
|
| Interest Expense | -1.91 | -1.65 | -1.62 | -1.81 | -1.56 | Upgrade
|
| Interest & Investment Income | 35.62 | 26.24 | 17.68 | 1.37 | 2.81 | Upgrade
|
| Earnings From Equity Investments | -1.21 | -0.07 | - | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | 14.09 | 13.29 | 17.55 | 10.29 | 11.37 | Upgrade
|
| EBT Excluding Unusual Items | 353.54 | 353.3 | 275.79 | 380.37 | 77.99 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | 19.5 | 409.96 | 44.38 | 1.61 | Upgrade
|
| Pretax Income | 353.54 | 372.8 | 685.75 | 424.76 | 79.59 | Upgrade
|
| Income Tax Expense | 63.21 | 70.58 | 134.86 | 84.25 | 13.81 | Upgrade
|
| Earnings From Continuing Operations | 290.34 | 302.22 | 550.89 | 340.51 | 65.78 | Upgrade
|
| Minority Interest in Earnings | -10.28 | -4.96 | 0.44 | 4.32 | 6.32 | Upgrade
|
| Net Income | 280.06 | 297.26 | 551.32 | 344.83 | 72.1 | Upgrade
|
| Net Income to Common | 280.06 | 297.26 | 551.32 | 344.83 | 72.1 | Upgrade
|
| Net Income Growth | -5.79% | -46.08% | 59.88% | 378.24% | -55.02% | Upgrade
|
| Shares Outstanding (Basic) | 767 | 715 | 677 | 653 | 654 | Upgrade
|
| Shares Outstanding (Diluted) | 767 | 752 | 710 | 657 | 654 | Upgrade
|
| Shares Change (YoY) | 2.04% | 5.83% | 8.22% | 0.40% | -0.26% | Upgrade
|
| EPS (Basic) | 0.37 | 0.42 | 0.81 | 0.53 | 0.11 | Upgrade
|
| EPS (Diluted) | 0.36 | 0.40 | 0.78 | 0.53 | 0.11 | Upgrade
|
| EPS Growth | -7.66% | -49.06% | 47.75% | 376.28% | -54.90% | Upgrade
|
| Free Cash Flow | 62.61 | 280.81 | 235.31 | 289.36 | 6.2 | Upgrade
|
| Free Cash Flow Per Share | 0.08 | 0.37 | 0.33 | 0.44 | 0.01 | Upgrade
|
| Dividend Per Share | 0.550 | 0.293 | 0.305 | 0.229 | 0.101 | Upgrade
|
| Dividend Growth | 87.91% | -3.91% | 33.13% | 127.21% | -47.61% | Upgrade
|
| Gross Margin | 45.00% | 44.63% | 41.92% | 47.42% | 30.34% | Upgrade
|
| Operating Margin | 23.49% | 26.10% | 23.10% | 32.32% | 10.12% | Upgrade
|
| Profit Margin | 21.43% | 24.59% | 52.58% | 30.08% | 11.17% | Upgrade
|
| Free Cash Flow Margin | 4.79% | 23.23% | 22.44% | 25.24% | 0.96% | Upgrade
|
| EBITDA | 386.08 | 394.01 | 311.92 | 438.54 | 128.16 | Upgrade
|
| EBITDA Margin | 29.54% | 32.60% | 29.75% | 38.26% | 19.85% | Upgrade
|
| D&A For EBITDA | 79.13 | 78.52 | 69.74 | 68.03 | 62.8 | Upgrade
|
| EBIT | 306.95 | 315.49 | 242.18 | 370.52 | 65.36 | Upgrade
|
| EBIT Margin | 23.49% | 26.10% | 23.10% | 32.32% | 10.12% | Upgrade
|
| Effective Tax Rate | 17.88% | 18.93% | 19.67% | 19.83% | 17.35% | Upgrade
|
| Revenue as Reported | 1,329 | 1,258 | 1,491 | 1,201 | 658.73 | Upgrade
|
Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.